The nation of Zimbabwe has declined a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's insistence on sensitive biological samples.
This move was revealed following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official representative later explained that the US was requesting genetic material for scientific study and commercial purposes while was not willing to share the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy said the US had furnished over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for more dialogue to find a agreement suitable to all parties so the nation's vital HIV treatment initiative can proceed.
Wider Implications
This development comes after a similar case in Kenya, where a high court blocked a similar health funding agreement following concerns were raised about the security of citizens' health data.
After returning to office recently, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.
The agency had administered assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government agreements to boost openness and accountability.
Based on statements, Sixteen nations in Africa have to date signed similar agreements, representing over $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"It is our view this partnership might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving HIV treatment through US-supported initiatives," the Ambassador said.
However, official spokesman Nick Mangwana said the proposed deal was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – like new medicines or tests – that could be developed from that provided information," his statement read.
"In essence, our nation would provide the raw materials for medical research without any assurance that the final treatments would be accessible to our population if a future pandemic arise."
National Interest and Global Health
He also said that the American exit from the global health body and its pursuit of bilateral health agreements were upending structures already established through the global organization.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This framework is designed to ensure that when a country contributes its information, the resulting advantages – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the capability to create them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how future collaboration could be designed in a way that honours the sovereignty and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but urged that talks need to persist since a large portion of the country's Aids initiatives relied on external financing.
"Where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be resolved via technical clarification and negotiated safeguards," the group commented.
The situation highlights the complex challenges between receiving much-needed international aid and protecting local interests in an increasingly interconnected world.